12.24
price down icon4.82%   -0.62
after-market After Hours: 12.23 -0.010 -0.08%
loading

Entrada Therapeutics Inc Stock (TRDA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
41.27%
59.12
41.85 43.73 18.17 25.26
Operating Expenses
2.88%
38.01
36.94 29.72 34.47 31.04
Benefits Costs and Expenses
100.00%
-
-84.31 - - -
Costs And Expenses
20.60%
38.01
47.87 29.72 34.47 31.04
Operating Income/Loss
330.44%
21.11
4.905 14.01 -16.30 -5.78
Income/Loss From Continuing Operations Before Tax
53.14%
59.12
126.15 43.73 -25.93 -6.674
Income Tax Expense/Benefit
90.23%
1.831
18.74 -17.40 13.85 3.551
Income/Loss From Continuing Operations After Tax
346.19%
23.50
-9.544 35.46 -25.93 -6.674
Net Income/Loss
346.19%
23.50
-9.544 35.46 -25.93 -6.674
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
31,100%
33.50
0.1074 33.28 33.16 32.37
Diluted Average Shares
2,908%
34.79
-1.2391 34.78 33.16 32.37
Basic Earnings Per Share
341.38%
0.70
-0.29 1.07 -0.78 -0.21
Diluted Earnings Per Share
342.86%
0.68
-0.28 1.02 -0.78 -0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Cap:     |  Volume (24h):